Client News

AFYREN and ESSE Skincare begin partnership to offer 100% natural cosmetic solutions with enhanced skincare performance

Newron announces the US initiation of its ENIGMA-TRS 2 Phase III global clinical study with evenamide as an add-on therapy for patients with treatment-resistant schizophrenia (TRS)

AL-S Pharma Reports Positive Results from Phase 2 Study of AP-101 for the Treatment of ALS, Supporting Plans for a Confirmatory Phase 3 Study

Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025

Formycon and MS Pharma sign exclusive commercialization partnership for Keytruda® biosimilar candidate FYB206 for the MENA Region

DoctorBox Adds Mainz Biomed’s ColoAlert® to Its Portfolio DNA-based Colorectal Cancer Screening as a Home Test

Rentschler Biopharma and Coriolis Pharma announce strategic collaboration for integrated biopharma solutions

Tacalyx Appoints Jean Engela as Chief Executive Officer to Spearhead Next Phase of Growth

CARBIOS and Wankai New Materials sign the definitive agreement establishing a strategic partnership to the large-scale deployment of CARBIOS’s PET biorecycling technology in Asia

AFYREN raises €23 million through share capital increase to finance optimization and expansion of unique biorefinery AFYREN NEOXY